| Literature DB >> 29290028 |
Valeria Perugini1, Mark Best1, Sandeep Kumar2, Anna L Guildford1, Adrian J Bone1, Wendy M Macfarlane1, Matteo Santin3, Gary J Phillips1.
Abstract
In vitro, pancreatic β-cells tend to reduce their ability to aggregate into islets and lose insulin-producing ability, likely due to insufficient cell-cell and cell-matrix interactions that are essential for β-cell retention, viability and functionality. In response to these needs, surfaces of succinylated chitosan-based beads (NSC) were modified with zwitterionic carboxy-betaine (CB) moieties, a compatible osmolyte known to regulate cellular hydration state, and used to promote the formation of β-cell spheroids using a conventional 2D cell culture technique. The NSC were synthesised by ionic gelation and surface-functionalised with CB using carbodiimide chemistry. Scanning electron microscopy (SEM), dynamic laser scattering (DLS) and Fourier transform infrared spectroscopy (FTIR) were employed as characterisation tools to confirm the successful modification of the succinylated chitosan material into spherical beads with rough surfaces and a diameter of 0.4 µm. NSC with and without CB were re-suspended at concentrations of 0.1, 0.3 and 0.6 mg/mL in saline medium and tested in vitro with MIN6 murine pancreatic β-cell line. Results showed that a concentration of 0.3 mg/mL, NSC-CB encouraged pancreatic MIN6 cells to proliferate and form spheroids via E-cadherin and Pdx-1 activation within 48 h in culture. These spheroids, with a size of approximately 80 µm, exhibited high cell viability and enhanced insulin protein expression and secretion when compared to cells organised by the non-modified beads.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29290028 PMCID: PMC5748029 DOI: 10.1007/s10856-017-6018-0
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN: 0957-4530 Impact factor: 3.896
Fig. 1Characterisation of NSC with and without CB. a FTIR; b SEM (scale bar is 1 µm) and c DLS analysis
Fig. 2Morphological changes of MIN6 cells cultured in various NSC conditions after 48 h incubation. White arrows indicate the formation of aggregates made by NSC-CB at 0.3 mg/mL. Scale bar is 100 µm
Fig. 3Spheroid formation. a Phase contrast images (scale bar is 100 µm) and b size of spheroids formed onto Matrigel substrates and NSC-CB at 0.3 mg/mL. *P ≤ 0.01; mean ± SD; n = 12
Fig. 4Detection of toxicity and cell proliferation of MIN6 cells treated with NSC and NSC-CB at distinct concentrations after 48 h incubation. Percentage of a viable cells, b apoptosis and c LDH (* P ≤ 0.05, mean ± SD compared TCP; n = 12); d western blotting analysis of Ki-67 expression compared to a positive control, GAPDH
Fig. 5Functional expression of E-cadherin activated within monolayer and spheroid-forming MIN6 cells tested with non-modified and modified NSC. a Localisation of E-cadherin is shown in green while blue represents DAPI staining of the nucleus (scale bar is 50 µm); b E-cadherin expression was quantified by measuring relative fluorescence unit (RFU) of the immunostaining. *P ≤ 0.01, mean ± SD; n = 12 (color figure online)
Fig. 6Regulation of both insulin and Pdx-1 proteins in MIN6 cells seeded with NSC and NSC-CB at 0.1, 0.3 and 0.6 mg/mL. a Insulin storage and b release by cells at 48 h (scale bar is 25 µm; *P ≤ 0.01; mean ± SD; n = 6); c characterisation of Pdx-1 expression analysed related to GAPDH by Western blotting